Related references
Note: Only part of the references are listed.Implications of anti-cytokine therapy in colorectal cancer and autoimmune diseases
Kepeng Wang et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Macrophage Polarization at the Crossroad Between HIV-1 Infection and Cancer Development
Massimo Alfano et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Targeting Interleukin-6 in Rheumatoid Arthritis
Md Yuzaiful Md Yusof et al.
DRUGS (2013)
Saquinavir-NO inhibits S6 kinase activity, impairs secretion of the encephalytogenic cytokines interleukin-17 and interferon-gamma and ameliorates experimental autoimmune encephalomyelitis
Filip Petkovic et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
Iron levels in polarized macrophages: Regulation of immunity and autoimmunity
Stefania Recalcati et al.
AUTOIMMUNITY REVIEWS (2012)
M1 and M2 Macrophages: Oracles of Health and Disease
Charles D. Mills
CRITICAL REVIEWS IN IMMUNOLOGY (2012)
Therapeutic Potential of Nitric Oxide-Modified Drugs in Colon Cancer Cells
Marija Mojic et al.
MOLECULAR PHARMACOLOGY (2012)
The new and less toxic protease inhibitor saquinavir-NO maintains anti-HIV-1 properties in vitro indistinguishable from those of the parental compound saquinavir
Filippo Canducci et al.
ANTIVIRAL RESEARCH (2011)
In vitro and in vivo anticancer action of Saquinavir-NO, a novel nitric oxide-derivative of the protease inhibitor saquinavir, on hormone resistant prostate cancer cells
Marco Donia et al.
CELL CYCLE (2011)
Tumor Cells and Tumor-Associated Macrophages: Secreted Proteins as Potential Targets for Therapy
Marc Baay et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2011)
Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer
Jermaine Coward et al.
CLINICAL CANCER RESEARCH (2011)
IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer
Markus F. Neurath et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2011)
IL-6 and leukemia-inhibitory factor are involved in the generation of tumor-associated macrophage: regulation by IFN-γ
Pascale Jeannin et al.
IMMUNOTHERAPY (2011)
Dual Roles of Immune Cells and Their Factors in Cancer Development and Progression
Brian F. Zamarron et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2011)
Human immunodeficiency virus protease inhibitors reduce the growth of human tumors via a proteasome-independent block of angiogenesis and matrix metalloproteinases
Elena Toschi et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Cytotoxic and Immune-Sensitizing Properties of Nitric Oxide-Modified Saquinavir in iNOS-Positive Human Melanoma Cells
Sanja Mijatovic et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2011)
IL-6: from its discovery to clinical applications
Tadamitsu Kishimoto
INTERNATIONAL IMMUNOLOGY (2010)
Anticancer Effects of the Nitric Oxide-Modified Saquinavir Derivative Saquinavir-NO against Multidrug-Resistant Cancer Cells
Florian Rothweiler et al.
NEOPLASIA (2010)
The antitumor properties of a nontoxic, nitric oxide-modified version of saquinavir are independent of Akt
Danijela Maksimovic-Ivanic et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Anti-HIV drugs for cancer therapeutics: back to the future?
Warren A. Chow et al.
LANCET ONCOLOGY (2009)
STATs in cancer inflammation and immunity: a leading role for STAT3
Hua Yu et al.
NATURE REVIEWS CANCER (2009)
Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: Potential targets of anti-cancer therapy
A Sica et al.
EUROPEAN JOURNAL OF CANCER (2006)
Antitumour effects of antiretroviral therapy
P Monini et al.
NATURE REVIEWS CANCER (2004)
Circulating interleukin-6 predicts survival in patients with metastatic breast cancer
R Salgado et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Nitric Oxide-Releasing Non Steroidal Anti-Inflammatory Drugs: A New Generation of Anti-Tumoral Molecules
Christian Lavagna et al.
CURRENT CANCER DRUG TARGETS (2003)
Long-term exposure to lifelong therapies
WG Powderly
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2002)
The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies
L Bingle et al.
JOURNAL OF PATHOLOGY (2002)
Share Paper
